Dodel R - Search Results

1

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group. Höglinger GU, et al. Among authors: dodel r. Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3. Mov Disord. 2017. PMID: 28467028 Free PMC article.

2

International guide to drugs for Parkinson's disease.

Oertel WH, Dodel RC. Oertel WH, et al. Among authors: dodel rc. Mov Disord. 1995 Mar;10(2):121-31. doi: 10.1002/mds.870100202. Mov Disord. 1995. PMID: 7753054

3

[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy].

Dodel RC, Pepperl S, Köhne-Volland R, Szucs T, Werhahn KJ, Noachtar S, Oertel WH. Dodel RC, et al. Med Klin (Munich). 1996 Jul 15;91(7):479-85. Med Klin (Munich). 1996. PMID: 8756119 Review. German.

4

Pallidal lesions. Structural and functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Paulus W, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Arch Neurol. 1996 Jul;53(7):682-6. doi: 10.1001/archneur.1996.00550070124020. Arch Neurol. 1996. PMID: 8929177

5

Activation mapping in essential tremor with functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Ann Neurol. 1997 Jan;41(1):32-40. doi: 10.1002/ana.410410108. Ann Neurol. 1997. PMID: 9005863

6

[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].

Dodel RC, Singer M, Köhne-Volland R, Selzer R, Scholz W, Rathay B, Oertel WH. Dodel RC, et al. Nervenarzt. 1997 Dec;68(12):978-84. doi: 10.1007/s001150050226. Nervenarzt. 1997. PMID: 9465341 German.

7

Costs of drug treatment in Parkinson's disease.

Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Dodel RC, et al. Mov Disord. 1998 Mar;13(2):249-54. doi: 10.1002/mds.870130209. Mov Disord. 1998. PMID: 9539337

8

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Dodel RC, Singer M, Köhne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1998 Sep;14(3):299-312. doi: 10.2165/00019053-199814030-00006. Pharmacoeconomics. 1998. PMID: 10186468

9

Dodel RC, Berger K, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 2001;19(10):1013-38. doi: 10.2165/00019053-200119100-00004. Pharmacoeconomics. 2001. PMID: 11735671 Review.

10

Cabergoline versus levodopa monotherapy: a decision analysis.

Smala AM, Spottke EA, Machat O, Siebert U, Meyer D, Köhne-Volland R, Reuther M, DuChane J, Oertel WH, Berger KB, Dodel RC. Smala AM, et al. Among authors: dodel rc. Mov Disord. 2003 Aug;18(8):898-905. doi: 10.1002/mds.10465. Mov Disord. 2003. PMID: 12889079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page